Searle Cytotec Pregnancy Reminder Issued As RU-486 Action Nears
Executive Summary
Searle issued a reminder Aug. 23 that its gastric ulcer treatment Cytotec (misoprostol) is contraindicated for use in pregnant women, about a month before FDA action is expected on the pending NDA for mifepristone.
You may also be interested in...
Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner
Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.
Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner
Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.
Pharmacia Cytotec Use For Labor Induction Reaffirmed By ACOG
The American College of Obstetricians & Gynecologists is reaffirming its guidelines supporting the use of Pharmacia/Searle's Cytotec (misoprostol) for the induction of labor.